Filing Details

Accession Number:
0001437749-22-028116
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-28 18:00:26
Reporting Period:
2022-11-25
Accepted Time:
2022-11-28 18:00:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1659617 Moleculin Biotech Inc. MBRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
938419 V Walter Klemp C/O Moleculin Biotech, Inc.
5300 Memorial Dr., Suite 950
Houston TX 77007
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-25 45,000 $1.28 409,890 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $1.25 to $1.30. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.